WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
Guoen Technology (02768) is scheduled to accept stock subscriptions from January 27 to January 30, with an expected listing date of February 4th.
CONANT OPTICAL (02276) plans to offer a discount of approximately 11.1% for the sale of 27 million shares, raising approximately HK$1.4 billion.
New stock news | Shenzhen Woer Heat-shrinkable Material submits application to Hong Kong Stock Exchange.
Guoen Technology (02768) is scheduled to accept stock subscriptions from January 27 to January 30, with an expected listing date of February 4th.
CONANT OPTICAL (02276) plans to offer a discount of approximately 11.1% for the sale of 27 million shares, raising approximately HK$1.4 billion.
New stock news | Shenzhen Woer Heat-shrinkable Material submits application to Hong Kong Stock Exchange.
RECOMMEND
Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026
Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026
Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026
